<?xml version="1.0" encoding="UTF-8"?>
<ref id="B205-microorganisms-07-00133">
 <label>205.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Edelman</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Tacket</surname>
    <given-names>C.O.</given-names>
   </name>
   <name>
    <surname>Wasserman</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Bodison</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Perry</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Perry</surname>
    <given-names>J.G.</given-names>
   </name>
  </person-group>
  <article-title>Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218</article-title>
  <source>Am. J. Trop. Med. Hyg.</source>
  <year>2000</year>
  <volume>62</volume>
  <fpage>681</fpage>
  <lpage>685</lpage>
  <pub-id pub-id-type="doi">10.4269/ajtmh.2000.62.681</pub-id>
  <pub-id pub-id-type="pmid">11304054</pub-id>
 </element-citation>
</ref>
